ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cruiser Capital Advisors, LLC | 36,888 | $301,000 | 0.15% |
| Kazazian Asset Management, LLC | 18,792 | $153,000 | 0.14% |
| Fiduciary Trust Co International of Pennsylvania | 202,100 | $1,649,000 | 0.07% |
| Engineers Gate Manager LP | 66,270 | $541,000 | 0.04% |
| THOMPSON DAVIS & CO., INC. | 1,534 | $13,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 23,700 | $193,000 | 0.02% |
| A.R.T. Advisors, LLC | 43,360 | $353,000 | 0.02% |
| Cutler Group LLC / CA | 20,822 | $186,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 63,614 | $519,000,000 | 0.01% |
| FNY Investment Advisers, LLC | 6,000 | $48,000 | 0.01% |